• Authors

Suggested:

Nasdaq-listed BioNexus Gene Lab announces adoption of Ethereum financial reserve strategy


2025-03-066462 Views
According to Globenewswire, the technology company BioNexus Gene Lab Corp. (NASDAQ stock code: BGLC), dedicated to technological innovation and healthcare, announced that its board of directors has officially approved the company's new Ethereum-focused financial strategy. This decision marks BGLC as the first NASDAQ-listed company to prioritize Ethereum as a strategic financial asset exclusively, in line with the recent announcement of Ethereum being included in the US "cryptocurrency strategic reserve".<br>




Contact Us : ymxbxkr@gmail.com